September 14, 2007 - In the largest study of its kind to date, comparing the CYPHER Sirolimus-eluting Coronary Stent and ...
Stents Drug Eluting
This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.
September 10, 2007 - Four analyses of three-year follow-up data that were presented at the ESC Congress 2007 showed that ...
Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES ...
iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the ...
September 5, 2007 – According to Boston Scientific Corp., results from the TAXUS WOMAN study, a gender specific analysis ...
September 6, 2007 – Boston Scientific Corp. announced at the ESC 2007 conference in Vienna, Austria, that results from ...
September 5, 2007 - Clinical investigators at the European Society of Cardiology Congress 2007 (ESC Congress 2007) ...
August 22, 2007 - Medtronic, Inc. announced it has been informed by the FDA that an Advisory Panel will review the ...
August 13, 2007 – A study published in the Journal of the American College of Cardiology showed that when ...
August 8, 2007 - A U.S. District Court judge enforced a settlement this week between Abbott Laboratories Inc. and ...
July 19, 2007 – Abbott announced that the first patient was enrolled in its XIENCE V SPIRIT WOMEN clinical trial, the ...
Source: Wall Street Journal Online
July 20, 2007 - U.S. doctors implanted fewer coronary stents in June than any other ...
July 17, 2007 - Boston Scientific Corp. today announced the implantation of its TAXUS Petal Bifurcation Paclitaxel ...
July 13, 2007 - Biotronik announced that it recently completed the enrollment of the ProLimus I First-In-Man trial to ...
June 20, 2007 — Sono-Tek Corporation recently announced the release of the MediCoat PSI, a system which offers ...